Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05647135

ImpACt of Very High Protein Content Enteral nUtrition Formulas on Critically Ill MUltipLe trAuma paTiEnts

This prospective observational randomized study aims to determine energy, protein intake and gastrointestinal tolerance while using enteral nutrition formulas with very high protein content and enteral nutrition formulas with normal protein content.

* Differences regarding achieving protein and calorie daily targets when using enteral nutrition formulas with different protein content * Differences regarding residual gastric volume when using enteral nutrition formulas with different protein content * Differences regarding body composition when using enteral nutrition formulas with different protein content

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Clinical Emergency Hospital of Bucharest

Bucharest, Romania

Location status: Recruiting

Location contact

Ana Maria Cotae, MD

PRINCIPAL_INVESTIGATOR

Angela Popa, MD

SUB_INVESTIGATOR

Cristian Cobilinschi, MD, PhD

CONTACT

[email protected]

+40765018776

Cristian Cobilinschi, MD, PhD

PRINCIPAL_INVESTIGATOR

Diana Iacob, MD

SUB_INVESTIGATOR

Ioana Dumitru, MD

SUB_INVESTIGATOR

Ioana Grintescu, MD, PhD

PRINCIPAL_INVESTIGATOR

Ioana Grințescu, Professor

CONTACT

[email protected]

+40722329187

Liliana Mirea, MD, PhD

PRINCIPAL_INVESTIGATOR

Mihaela Buiuc, MD

SUB_INVESTIGATOR

Raluca Ungureanu, MD, PhD

PRINCIPAL_INVESTIGATOR

About this study

ImpACt of very high protein Content enteral nUtrition formulas on protein metabolism and residual gastric volume in critically ill MUltipLe trAuma paTiEnts

  • ACCUMULATE trial -

Background and rationale:

Despite an increased survival among critically ill patients, many of the ICU "survivors" may develop prolonged functional disabilities. It has already been proven that nutritional therapy is essential, considering that an adequate provision of calories and proteins may influence patients prognostic.

Multiple trauma patients are on a particular nutritional risk, since their high nitrogen demands and associated nutritional therapy challenges, caused by repeated surgical intervention or multiple imagistic procedures. Although nutritional therapy impact on mortality is still in debate, clear, positive results were obtained in decreasing ICU and hospital stay after adequate nutritional support.

According to ESPEN guideline on clinical nutrition in the ICU early enteral nutrition (within 48 h) should be initiated in order to assure an adequate calorie and protein intake. Beside optimal timing, the management of nutrition therapy in critically ill patients should also integrate the optimal route and caloric/protein targets.

Energy requirements monitoring through indirect calorimetry has been proposed as a standard-of-care method for critically ill patients, considering its proven superiority towards predictive equation.

Beyond calorie intake, proteins proved to play a central role in maintain lean body mass, healing wounds and supporting immune function.For multiple trauma patients it was reported that protein losses may reach 14 % of the total body stores, thus this type of patients are exposed to a particular increased risk of protein deficits. If calorie administration benefits from a proper monitoring tool, protein requirements are still based on predictive equation. The impact of protein administration is also lacking of direct measurements techniques. Lean body mass evaluation by ultrasound and computerized tomography has been reported to have a good correlation with hospital stay and pots-ICU functional capacity. Moreover muscle function evaluation through a hand-grip dynamometer was also tested with good results in patients with ARDS.

Source of administered protein may also influence nitrogen balance, considering that whey proteins (rich in leucine) promote a slower hydrolysis and allow a longer period for absorption.

Reaching the recommended goals is often impeded by gastric intolerance manifested through increased gastric volume residues. It has been already demonstrated that large gastric volume residues are associated with impaired absorption and an increased incidence of aspiration pneumonia.

Gastrointestinal dysfunction in multiple trauma patients admitted to the intensive care unit (ICU) is an important yet underrecognized consequence. There are various causes of gastrointestinal tract dysfunction mostly related to patients general health condition and to their diagnostics. Gastrointestinal failure may be induced by several factors like immunological, biological and mechanical barrier disruption and it may be manifested through stress ulceration, bacterial translocation, ileus, intra-abdominal hypertension, diarrhoea and constipation.

Whether residual gastric volume monitoring should be regularly performed has been extensively discussed. Although the results from some randomised trials which focused on monitoring gastric residual volume, did not find any difference in outcomes, this measurement was far for being abandoned. Moreover, gastric residual volume monitoring is still an essential component of enteral nutrition patient care.

Although several monitoring methods for gastric volume residue measurements were described, there is no generally accepted technique for daily use.

Objective:

This prospective observational randomized study aims to determine energy, protein intake and gastrointestinal tolerance while using enteral nutrition formulas with very high protein content and enteral nutrition formulas with normal protein content.

Safety points:

  • Clinical parameters - vomiting, diarrhoea
  • Biochemical parameters - base excess, urea levels
  • Daily gastric residual volume evaluation using ultrasound gastric antrum measurements after 24 hours of continuous enteral nutrition administration using both types of formulas;

Study population Consecutive patients with multiple trauma intubated and mechanical ventilated, admitted to the intensive care unit (ICU).

Sample size calculation Since the hypotheses of the study are exploratory, no formal sample size calculation has been performed. This prospective observational study aims to recruit>70 multiple trauma patients.

Randomization:

Simple randomization method will be used to assign subjects into two groups A and B.

Ethical considerations:

This study will be conducted in full conformity with the Declaration of Helsinki and Good Clinical Practices.

Local ethical committee approval will be asked before any patient will be included.

Considering that nutritional support has become a standard-of-care in every intensive care unit in the world, it is considered that this research is based on collecting data routinely available for every critically ill patient. Although no intervention is performed an informed consent will be provided.

Taking into account that the included patients are not able to provide informed consent at the time of recruitment (on ICU admission), a Power of Attorney or a Legal tutor will act as Consultee and will be asked to consent/decline participation to the study on legal behalf of the patient. If patients have Advance Decision Plan including participation in research studies the Plan will be respected and recruitment pursued/abandoned accordingly.

After regaining capacity, all patients will be asked to provide Informed Consent for using their personal data and will be given the possibility to:

Provide Informed Consent for the acute data and follow-up. Deny research participation and request destruction of acute data collected.

Study participant research data, which is for purposes of statistical analysis and scientific reporting, will be transmitted to the Data Manager and the Statistician of the study.

Expected impact of the study KNOWLEDGE The investigators aim to provide a detailed description of protein administration using two different types of enteral formulas. The main objectives of the study are to evaluate energy, protein intake and gastrointestinal tolerance while using enteral nutrition formulas with different protein content. Nevertheless, the investigators want to provide data about the impact of these different enteral nutrition formulas on body composition as well as on functionality.

Regarding of the obtained data a change on local and national recommendation considering enteral nutrition in multiple trauma patients is to be expected.

Funding All the enteral nutrition products are donated by the Nutricia Global. No funding will be received for this study.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult patients (>18 yrs) admitted to the ICU
  • Multiple trauma (Injury severity score > 18)
  • Intubation and mechanical ventilation upon admission in ICU or during the first 24 hours of admission, for at least 48 h

Exclusion criteria

  • Age < 18 years
  • Pregnant women
  • Patients not intubated or not mechanically ventilated or receiving only non-invasive ventilation
  • Patients with enteral feeding contraindication 48 h after admission
  • Patients with recent gastrointestinal surgical intervention
  • Patients on chronic therapy with corticosteroids

Treatment and study plan

Medical Food

Other

enteral formulas with different protein composition

Primary outcomes

  1. Calorie and protein target

    Time frame: on day 5 days

    Differences regarding achieving protein and calorie daily targets in grams per kilogram of body weight (g/kg BW) at day 5 of the intervention period and at day 10 when using enteral nutrition formulas with different protein content

  2. Calorie and protein target

    Time frame: on day 10

    Differences regarding achieving protein and calorie daily targets in grams per kilogram of body weight (g/kg BW) at day 5 of the intervention period and at day 10 when using enteral nutrition formulas with different protein content

Secondary outcomes

  1. Ultrasound-guided assessment of gastric residual volume

    Time frame: on day 5

    Differences regarding residual gastric volume when using enteral nutrition formulas with different protein content.

    Ultrasound assessment of gastric volume using a current model for GV assessment based on antral cross-sectional area (CSA) - GV (ml)1⁄427.0+14.6×right-lateral CSA (cm2)21.28×age (yr)

  2. Ultrasound-guided assessment of gastric residual volume

    Time frame: on day 10

    Differences regarding residual gastric volume when using enteral nutrition formulas with different protein content.

    Ultrasound assessment of gastric volume using a current model for GV assessment based on antral cross-sectional area (CSA) - GV (ml)1⁄427.0+14.6×right-lateral CSA (cm2)21.28×age (yr)

  3. Muscle function

    Time frame: 24 hours after extubation

    Muscle function evaluation using handgrip dynamometer after extubation and sedation cessation

  4. Muscle function

    Time frame: 5 days after extubation

    Muscle function evaluation using handgrip dynamometer after extubation and sedation cessation

  5. Body composition - Fat-free body mass

    Time frame: 24 hours after extubation

    Fat-free body mass assessment using bioelectrical impedance analysis

  6. Body composition - Fat-free body mass

    Time frame: 5 days after extubation

    Fat-free body mass assessment using whole-body bioelectrical impedance

  7. Body composition - Total body water

    Time frame: 24 hours after extubation

    Total body water assessment using whole-body bioelectrical impedance analysis

  8. Body composition - Total body water

    Time frame: 5 days after extubation

    Total body water assessment using whole-body bioelectrical impedance analysis

  9. Body composition - Phase angle

    Time frame: 24 hours after extubation

    Phase angle measurement using whole-body bioelectrical impedance analysis

  10. Body composition - Phase angle

    Time frame: 5 days after extubation

    Phase angle measurement using whole-body bioelectrical impedance analysis

  11. Body composition - ultrasound

    Time frame: baseline (on admission/first 24 hours)

    Quadriceps rectus femoris thickness thickness measured by B-mode ultrasonography

  12. Body composition - ultrasound

    Time frame: on day 5

    Quadriceps rectus femoris thickness measured by B-mode ultrasonography

  13. Body composition - ultrasound

    Time frame: on day 10

    Quadriceps rectus femoris thickness measured by B-mode ultrasonography

  14. Body composition - ultrasound

    Time frame: on day 15

    Quadriceps rectus femoris thickness measured by B-mode ultrasonography

  15. Inflammation - CRP

    Time frame: on day 5

    Plasmatic levels of C-reactive protein

  16. Inflammation - CRP

    Time frame: on day 10

    Plasmatic levels of C-reactive protein

  17. Inflammation - prealbumin

    Time frame: on day 5

    Plasmatic levels of prealbumin

  18. Inflammation - prealbumin

    Time frame: on day 10

    Plasmatic levels of prealbumin

Study contacts

Contact information is provided by the study sponsor or research team.

Cristian Cobilinschi, MD, PhD

CONTACT

[email protected]

+40765018776

Ioana Grintescu, MD, PhD

CONTACT

[email protected]

+40722329187

Sponsors and collaborators

Lead sponsor

Romanian Society for Enteral and Parenteral Nutrition

Other

Registry information

Official study title

ImpACt of Very High Protein Content Enteral nUtrition Formulas on Protein Metabolism and Residual Gastric Volume in Critically Ill MUltipLe trAuma paTiEnts

Acronym: ACCUMULATE

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Dec 12, 2022
Registry last updated
Jul 22, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.